Accelerating Expansion in the Latin American Market

Medytox announced on September 2 that it has received product approval from Colombia's National Food and Drug Surveillance Institute (INVIMA) for three types of hyaluronic acid fillers: 'Attier Classic,' 'Intensive,' and 'Volume.'


Colombia, known for its excellent medical services and strong demand for aesthetic medicine, is a key market in the Latin American aesthetic industry. Following Brazil and Mexico, it has formed the third largest medical device market in the region.


Medytox Attier 3 Types. Medytox

Medytox Attier 3 Types. Medytox

View original image

Medytox stated, "With this approval, we have established an aesthetic portfolio in Colombia encompassing hyaluronic acid fillers such as Neuramis and Attier, as well as the botulinum toxin product Meditoxin. By building a foundation to proactively meet the diverse procedural needs of local medical professionals, we expect to further strengthen our competitiveness in the market."



Medytox also plans to continue expanding its presence in neighboring Latin American countries, centered on Colombia, to broaden its global influence.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing